Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 27 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.65 Insider Own19.41% Shs Outstand46.34M Perf Week17.84%
Market Cap135.75M Forward P/E- EPS next Y-2.55 Insider Trans0.95% Shs Float38.52M Perf Month37.86%
Income-124.08M PEG- EPS next Q-0.79 Inst Own54.83% Short Float13.08% Perf Quarter78.62%
Sales0.00M P/S- EPS this Y-0.82% Inst Trans11.60% Short Ratio9.94 Perf Half Y16.87%
Book/sh1.98 P/B1.44 EPS next Y7.81% ROA-72.89% Short Interest5.04M Perf Year-1.05%
Cash/sh2.96 P/C0.96 EPS next 5Y- ROE-104.56% 52W Range1.24 - 4.07 Perf YTD15.45%
Dividend Est.- P/FCF- EPS past 5Y-34.47% ROI-129.31% 52W High-30.19% Beta1.02
Dividend TTM- Quick Ratio4.14 Sales past 5Y-71.14% Gross Margin- 52W Low129.03% ATR (14)0.27
Dividend Ex-Date- Current Ratio4.14 EPS Y/Y TTM3.20% Oper. Margin0.00% RSI (14)60.59 Volatility8.64% 12.66%
Employees66 Debt/Eq0.03 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price11.67
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-1.40% Payout- Rel Volume1.25 Prev Close2.47
Sales Surprise- EPS Surprise9.57% Sales Q/Q- EarningsNov 07 AMC Avg Volume506.85K Price2.84
SMA2017.38% SMA5021.40% SMA20017.59% Trades Volume626,552 Change14.98%
Date Action Analyst Rating Change Price Target Change
Sep-15-22Initiated JMP Securities Mkt Outperform $17
May-05-22Downgrade Credit Suisse Outperform → Neutral $35 → $5
Mar-21-22Initiated H.C. Wainwright Buy $25
Oct-15-21Resumed BTIG Research Buy $68
Jun-28-21Initiated ROTH Capital Buy $75
May-05-21Resumed Credit Suisse Outperform $68
Apr-26-21Resumed Credit Suisse Outperform $68
Jan-11-21Initiated JP Morgan Overweight $45
Jan-11-21Initiated Jefferies Buy $51
Jan-11-21Initiated Credit Suisse Outperform $49
Dec-20-23 08:00AM
Dec-13-23 08:00AM
Dec-06-23 08:00AM
Dec-05-23 08:00AM
Nov-30-23 08:00AM
08:00AM Loading…
Nov-28-23 08:00AM
Nov-12-23 09:24AM
Nov-07-23 04:01PM
Nov-06-23 04:05PM
Oct-12-23 07:30AM
Oct-10-23 07:30AM
Sep-06-23 08:00AM
Aug-03-23 04:01PM
Aug-02-23 11:31AM
04:01PM Loading…
Aug-01-23 04:01PM
Jul-25-23 08:00AM
Jul-07-23 07:09AM
Jun-26-23 08:00AM
May-31-23 08:00AM
May-11-23 04:01PM
May-08-23 04:05PM
May-04-23 08:00AM
Apr-29-23 09:29AM
Mar-31-23 06:36AM
Mar-27-23 07:12AM
Mar-24-23 11:31AM
Mar-23-23 04:05PM
Mar-16-23 08:00AM
Feb-27-23 08:07AM
08:00AM Loading…
Feb-23-23 08:00AM
Jan-25-23 07:10AM
Jan-10-23 08:00AM
Dec-29-22 04:05PM
Dec-22-22 08:00AM
Dec-08-22 08:54AM
Dec-01-22 09:55AM
Nov-15-22 09:55AM
Nov-11-22 08:38AM
Nov-08-22 08:00AM
Nov-04-22 11:15AM
Nov-03-22 04:01PM
Oct-27-22 08:00AM
Sep-23-22 09:15AM
Sep-21-22 10:14AM
Sep-12-22 10:08AM
Aug-18-22 06:39AM
Aug-09-22 07:25PM
Aug-03-22 08:00AM
Aug-02-22 08:00AM
Jun-04-22 08:12AM
Jun-01-22 04:05PM
May-04-22 04:01PM
Apr-08-22 08:00AM
Mar-01-22 06:00AM
Feb-07-22 05:38PM
Jan-10-22 04:05PM
Dec-21-21 09:00AM
Dec-11-21 06:34AM
Nov-15-21 05:09PM
Oct-04-21 10:56AM
Sep-29-21 08:03AM
Sep-12-21 08:49AM
Aug-13-21 05:54PM
Jun-14-21 02:03AM
May-12-21 06:26PM
Mar-16-21 01:59AM
Dec-18-20 04:00PM
Dec-16-20 05:34PM
Dec-15-20 07:59PM
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCBRINN SYLVIADirectorDec 26Buy2.334,0009,32015,125Dec 26 07:43 PM
SHORT JAY M PHDChief Executive OfficerDec 20Buy2.1450,000106,9101,439,283Dec 20 06:27 PM
STEINMAN LAWRENCEDirectorDec 19Buy2.0520,00041,04838,459Dec 19 08:24 PM
Vasquez ChristianSee RemarksDec 19Buy2.047,49515,262115,659Dec 19 04:33 PM
MCBRINN SYLVIADirectorSep 08Buy2.542,0005,08011,125Sep 13 06:55 PM
SHORT JAY M PHDChief Executive OfficerMar 29Buy2.4740,800100,8621,412,387Mar 30 07:17 PM
Vasquez ChristianSee RemarksMar 28Buy2.4020,00047,970102,709Mar 29 05:20 PM
MCBRINN SYLVIADirectorMar 28Buy2.354,0009,40019,125Jan 19 04:21 PM